ARCHIVES

FDA Approves Manufacturer Of IVAX Paclitaxel Ingredient.

This article is from The Cancer Letter archive.

Vol. 27 No. 26 | June 29, 2001

Download PDF Visit The Full Archive

Related Articles

NCI subsidy of $2 million paid major expenses of rescheduled meeting.

April 15, 2005

Insurance Co. Official Says Cancer Centers, Insurers Are “Allies”

June 2, 1995

DRCCA Board Changes Center Core Grants Guidelines To Permit Payment for Control Program Directors

October 29, 1982

NCI Plans $30 Million In Patient-Oriented Chemoprevention research In Next 5 Years

December 6, 1996

NIH Establishes Women’s Health Office, Responds To Criticism

September 14, 1990

In Brief: Sullivan Rejects Oregon Medicaid Rationing Plan; Howe To Head National Marrow Donor Program

August 7, 1992